0001994145-25-000001.txt : 20250220 0001994145-25-000001.hdr.sgml : 20250220 20250220111327 ACCESSION NUMBER: 0001994145-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250220 DATE AS OF CHANGE: 20250220 EFFECTIVENESS DATE: 20250220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnZeta Immunotherapies, Inc. CENTRAL INDEX KEY: 0001994145 ORGANIZATION NAME: IRS NUMBER: 932672754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-538757 FILM NUMBER: 25643856 BUSINESS ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: 9173644613 MAIL ADDRESS: STREET 1: 122 SEVILLA AVE # 1814 CITY: CORAL GABLES STATE: FL ZIP: 33134 D 1 primary_doc.xml X0708 D LIVE 0001994145 EnZeta Immunotherapies, Inc. 122 SEVILLA AVE # 1814 CORAL GABLES FL FLORIDA 33134 9173644613 DELAWARE None None Corporation true 2023 Paul Kelly 122 Sevilla Avenue, Suite 1814 Coral Gables FL FLORIDA 33134 Executive Officer Director Sergio Traversa 2222 PONCEDELEON BLVD. 3RD FLOOR Coral Gables FL FLORIDA 33134 Director Biotechnology Decline to Disclose 06b false 2025-02-17 false true true false 50000 1000000 200000 800000 false 3 0 0 0 false EnZeta Immunotherapies, Inc. /s/ Paul Kelly Paul Kelly President 2025-02-20